Values First Advisors Inc. Buys 371 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Values First Advisors Inc. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,511 shares of the medical equipment provider’s stock after purchasing an additional 371 shares during the quarter. Values First Advisors Inc.’s holdings in Intuitive Surgical were worth $510,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. OFI Invest Asset Management bought a new stake in shares of Intuitive Surgical in the 3rd quarter worth approximately $25,000. Headinvest LLC bought a new position in shares of Intuitive Surgical during the third quarter valued at $28,000. Stone House Investment Management LLC increased its holdings in shares of Intuitive Surgical by 100.0% during the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 50 shares in the last quarter. Householder Group Estate & Retirement Specialist LLC purchased a new stake in shares of Intuitive Surgical during the third quarter valued at $30,000. Finally, Truvestments Capital LLC boosted its position in shares of Intuitive Surgical by 137.2% during the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 59 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on ISRG. Piper Sandler raised their target price on Intuitive Surgical from $325.00 to $425.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 24th. Raymond James raised their target price on Intuitive Surgical from $372.00 to $435.00 and gave the stock an “outperform” rating in a research report on Thursday, January 25th. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Mizuho raised their target price on Intuitive Surgical from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Thursday, January 25th. Finally, Royal Bank of Canada lifted their price objective on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $371.60.

Intuitive Surgical Trading Down 0.3 %

Shares of NASDAQ ISRG traded down $1.01 during trading hours on Thursday, hitting $399.09. 1,124,747 shares of the company traded hands, compared to its average volume of 1,673,996. The stock has a market capitalization of $141.46 billion, a price-to-earnings ratio of 79.30, a price-to-earnings-growth ratio of 6.17 and a beta of 1.36. The company’s 50 day moving average price is $385.19 and its 200 day moving average price is $332.83. Intuitive Surgical, Inc. has a 12 month low of $246.63 and a 12 month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The company had revenue of $1.93 billion during the quarter, compared to analysts’ expectations of $1.89 billion. During the same quarter in the previous year, the business earned $0.91 EPS. Intuitive Surgical’s revenue was up 16.6% compared to the same quarter last year. Equities analysts anticipate that Intuitive Surgical, Inc. will post 4.93 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 4,318 shares of the business’s stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70. Following the completion of the transaction, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In related news, EVP Myriam Curet sold 4,318 shares of the company’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the transaction, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark Brosius sold 196 shares of the company’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at $736,800. The disclosure for this sale can be found here. In the last ninety days, insiders sold 248,418 shares of company stock worth $95,927,097. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.